PatientsVille.com Logo

PatientsVille

Betamethasone Side Effects

Common Betamethasone Side Effects


The most commonly reported Betamethasone side effects (click to view or check a box to report):

Erythema (26)
Condition Aggravated (24)
Malaise (19)
Pyrexia (18)
Dyspnoea (18)
Exposure During Pregnancy (17)
Caesarean Section (16)
Anaphylactic Shock (15)
Nausea (14)
Premature Baby (13)
Injection Site Pain (13)
Stevens-johnson Syndrome (12)
Fall (12)
Injection Site Erythema (12)
Pruritus (12)
Hepatic Function Abnormal (11)
Hyperglycaemia (11)
Toxic Anterior Segment Syndrome (11)
Maternal Exposure During Pregnancy (11)
Hyperhidrosis (11)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Betamethasone Side Effects Reported to FDA

The following Betamethasone reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Betamethasone on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Hyperglycaemia, Hepatic Function Abnormal, Blood Creatine Phosphokinase Increased, Maternal Exposure During Pregnancy
This is a report of a 39-year-old female patient (weight: NA) from JP, suffering from the following symptoms/conditions: NA, who was treated with Betamethasone Sodium Phosphate (dosage: 12 Mg, Qd, start time: Aug 06, 2013), combined with:
  • Ritodrine (200mc/d)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Hyperglycaemia
  • Hepatic Function Abnormal
  • Blood Creatine Phosphokinase Increased
  • Maternal Exposure During Pregnancy
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Betamethasone Sodium Phosphate treatment in female patients, resulting in hyperglycaemia side effect.

Exposure During Pregnancy
This report suggests a potential Betamethasone Exposure During Pregnancy side effect(s) that can have serious consequences. A 38-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: NA and used Betamethasone (dosage: At 24 Weeks? Gestation) starting NS. Soon after starting Betamethasone the patient began experiencing various side effects, including:
  • Exposure During Pregnancy
Drugs used concurrently: NA. Although Betamethasone demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as exposure during pregnancy, may still occur.

International Normalised Ratio Increased
This International Normalised Ratio Increased problem was reported by a consumer or non-health professional from JP. A 79-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: prurigo,staphylococcal infection,intracranial venous sinus thrombosis,deep vein thrombosis,hypochromic anaemia,gastritis,dementia alzheimer^s type,hypothyroidism,bacteraemia. On May 10, 2013 this consumer started treatment with Betamethasone Sodium Phosphate (dosage: 1.25 Mg, Qd). The following drugs were being taken at the same time:
  • Baktar (4 Df, Qd)
  • Warfarin (3.5 Mg, Qd)
  • Warfarin
  • Ferromia (0.6 G, Qd)
  • Gaster (40 Mg, Qd)
  • Risperdal (0.5 Mg, Qd)
  • Thyradin-s (12.5 Microgram, Qd)
  • Zyvox (1200 Mg, Qd)
When commencing Betamethasone Sodium Phosphate, the patient experienced the following unwanted symptoms/side effects:
  • International Normalised Ratio Increased
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as international normalised ratio increased, may become evident only after a product is in use by the general population.

Anxiety, Gait Disturbance, Impaired Driving Ability
This is a report of a 85-year-old female patient (weight: NA) from US. The patient developed the following symptoms/conditions: bursitis and was treated with Betamethasone (dosage: NA) starting May 05, 2009. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Anxiety
  • Gait Disturbance
  • Impaired Driving Ability
The patient was hospitalized and became disabled. This opens a possibility that Betamethasone treatment could cause the above reactions, including anxiety, and some female subjects may be more susceptible.


Enterococcal Infection, Exposure During Pregnancy
A 31-year-old female patient (weight: NA) from PL with the following symptoms/conditions: NA started Betamethasone treatment (dosage: 24 Mg, Unk) on NS. Soon after starting Betamethasone treatment, the subject experienced various side effects, including:
  • Enterococcal Infection
  • Exposure During Pregnancy
Concurrently used drugs:
  • Fenoterol (5mg X 8/day)
  • Verapamil (40mgx4/day)
This finding indicates that some female patients could be more vulnerable to Betamethasone.

Exposure During Pregnancy
A 20-year-old female patient from US (weight: NA) experienced symptoms, such as: NA and was treated with Betamethasone(dosage: NA). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
  • Exposure During Pregnancy
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Betamethasone efficacy:
  • Labetalol Hydrochloride
  • Magnesium Sulfate


Meningitis
In this report, Betamethasone was administered for the following condition: headache.A 45-year-old male consumer from US (weight: NA) started Betamethasone treatment (dosage: NA) on Sep 20, 2012.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Meningitis
A possible interaction with other drugs could have contributed to this reaction: NA.The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Betamethasone treatment could be related to the listed above side effect(s).

Exposure During Pregnancy
This is a report of the following Betamethasone Dipropionate side effect(s):
  • Exposure During Pregnancy
A 35-year-old female patient from US (weight: NA) presented with the following condition: premature delivery and received a treatment with Betamethasone Dipropionate (dosage: 2 Df, Unk) starting: NS.The following concurrently used drugs could have generated interactions: NA.This report suggests that a Betamethasone Dipropionate treatment could be associated with the listed above side effect(s).

Exposure During Pregnancy
This Betamethasone Dipropionate report was submitted by a 23-year-old female consumer from US (weight: NA). The patient was diagnosed with: premature delivery and Betamethasone Dipropionate was administered (dosage: NA) starting: NS. The consumer developed a set of symptoms:
  • Exposure During Pregnancy
Other drugs used simultaneously:
  • Magnesium Sulfate
  • Cefazolin
  • Oxytocin
Those unexpected symptoms could be linked to a Betamethasone Dipropionate treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Psoriasis, Hypertension
This is a report of a possible correlation between Betamethasone Dipropionate use and the following symptoms/side effect(s):
  • Psoriasis
  • Hypertension
which could contribute to an assessment of Betamethasone Dipropionate risk profile.A male consumer from US (weight: NA) was suffering from psoriasis and was treated with Betamethasone Dipropionate (dosage: NA) starting 2002.Other concurrent medications:
  • Atenolol


Application Site Pain, Allergy To Chemicals
A 89-year-old female patient from US (weight: NA) presented with the following symptoms: rash and after a treatment with Betamethasone Dipropionate (dosage: NA) experienced the following side effect(s):
  • Application Site Pain
  • Allergy To Chemicals
The treatment was started on 201204. Betamethasone Dipropionate was used in combination with the following drugs: NA.This report could alert potential Betamethasone Dipropionate consumers.

Disseminated Tuberculosis
In this report, a 74-year-old patient from JP (weight: NA) was affected by a possible Betamethasone Sodium Phosphate side effect.The patient was diagnosed with polymyalgia rheumatica. After a treatment with Betamethasone Sodium Phosphate (dosage: 1 Mg, Qd, start date: 200912), the patient experienced the following side effect(s):
  • Disseminated Tuberculosis
The following simultaneously used drugs could have led to this reaction: NA.The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Betamethasone Sodium Phosphate treatment.

Pulmonary Oedema, Maternal Exposure During Pregnancy, Normal Newborn
This is a report of a 27-year-old female patient from JP (weight: NA), who used Betamethasone Sodium Phosphate (dosage: Unk) for a treatment of NA. After starting a treatment on NS, the patient experienced the following side effect(s):
  • Pulmonary Oedema
  • Maternal Exposure During Pregnancy
  • Normal Newborn
The following drugs could possibly have interacted with the Betamethasone Sodium Phosphate treatment
  • Ritodrine Hydrochloride (50 Microgram/min)
Taken together, these observations suggest that a Betamethasone Sodium Phosphate treatment could be related to side effect(s), such as Pulmonary Oedema, Maternal Exposure During Pregnancy, Normal Newborn.

Osteonecrosis
This osteonecrosis side effect was reported by a consumer or non-health professional from JP. A 37-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Betamethasone (dosage: Unk), which was started on 200910. Concurrently used drugs:
  • Betamethasone Sodium Phosphate (Unk)
When starting to take Betamethasone the consumer reported the following symptoms:
  • Osteonecrosis
These side effects may potentially be related to Betamethasone.

Adrenal Insufficiency
This is a Betamethasone Sodium Phosphate side effect report of a 65-year-old female patient (weight:NA) from JP, suffering from the following symptoms/conditions: parosmia, who was treated with Betamethasone Sodium Phosphate (dosage:3 Drops, start time: 2002), combined with:
  • Mucodyne (1500 Mg, Qd)
  • Toki-shakuyaku-san (7.5 Mg, Qd)
  • Methycobal (1500 Mg, Qd)
  • Onealfa (1 Microgram, Qd)
  • Lipovas (simvastatin) (5 Mg, Qd)
  • Ferromia (50 Mg, Qd)
, and developed a serious reaction and a adrenal insufficiency side effect. The patient presented with:
  • Adrenal Insufficiency
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Betamethasone Sodium Phosphate treatment in female patients suffering from parosmia, resulting in adrenal insufficiency.

Dyspepsia, Gastrooesophageal Reflux Disease
This report suggests a potential Betamethasone dyspepsia side effect(s) that can have serious consequences. A 49-year-old female patient from SE (weight:NA) was diagnosed with the following health condition(s): nausea,breast cancer and used Betamethasone (dosage: NA) starting Feb 04, 2013. Soon after starting Betamethasone the patient began experiencing various side effects, including:
  • Dyspepsia
  • Gastrooesophageal Reflux Disease
Drugs used concurrently:
  • Sendoxan (Unk)
  • Sendoxan (Unk)
  • Epirubicin Hydrochloride (Unk)
  • Epirubicin Hydrochloride (Unk)
  • Fluorouracil (Unk)
  • Fluorouracil (Unk)
The patient was hospitalized. Although Betamethasone demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as dyspepsia, may still occur.

Dermatitis Contact
This dermatitis contact problem was reported by a consumer or non-health professional from JP. A 63-year-old male patient (weight: NA) was diagnosed with the following medical condition(s): cataract.On 2010 a consumer started treatment with Betamethasone Sodium Phosphate (dosage: Unk). The following drugs/medications were being taken at the same time:
  • Ecolicin (Unk)
  • Sanbetason (Unk)
  • Neo-medrol (Unk)
  • Rinbeta Pf (Unk)
  • Diclod (Unk)
  • Cravit (Unk)
  • Bestron (Unk)
When commencing Betamethasone Sodium Phosphate, the patient experienced the following unwanted symptoms /side effects:
  • Dermatitis Contact
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as dermatitis contact, may become evident only after a product is in use by the general population.

Pulmonary Oedema
This is a Betamethasone Sodium Phosphate side effect report of a 27-year-old female patient (weight: NA) from JP. The patient developed the following symptoms/conditions: neonatal respiratory distress syndrome prophylaxis,threatened labour and was treated with Betamethasone Sodium Phosphate (dosage: 12 Mg, Qd) starting NS. Concurrently used drugs:
  • Ritodrine Hydrochloride (200 Mcg/minute)
  • Ritodrine Hydrochloride (150 Mcg/minute)
  • Magnesium Sulfate (0.5 G, Qh)
  • Magnesium Sulfate (0.8 G, Qh)
Soon after that, the consumer experienced the following of symptoms:
  • Pulmonary Oedema
This opens a possibility that Betamethasone Sodium Phosphate could cause pulmonary oedema and that some female patients may be more susceptible.

Exposure During Pregnancy, Loss Of Consciousness, Craniectomy, Haemorrhage, Disseminated Intravascular Coagulation, Caesarean Section, Somnolence
A 35-year-old female patient (weight: NA) from CA with the following symptoms: NA started Betamethasone treatment (dosage: 12 Mg, Once) on NS. Soon after starting Betamethasone treatment, the consumer experienced several side effects, including:
  • Exposure During Pregnancy
  • Loss Of Consciousness
  • Craniectomy
  • Haemorrhage
  • Disseminated Intravascular Coagulation
  • Caesarean Section
  • Somnolence
. Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Betamethasone side effects, such as exposure during pregnancy.

Ophthalmic Herpes Simplex
This ophthalmic herpes simplex side effect was reported by a physician from JP. A 71-year-old female patient (weight:NA) experienced the following symptoms/conditions: uveitis,ophthalmic herpes simplex.The patient was prescribed Betamethasone (dosage: 0.1%), which was started on NS. Concurrently used drugs:
  • Aciclovir
.When starting to take Betamethasone the consumer reported symptoms, such as:
  • Ophthalmic Herpes Simplex
These side effects may potentially be related to Betamethasone.

Corneal Perforation, Ulcerative Keratitis
This is a report of a 76-year-old male patient (weight: NA) from JP, suffering from the following symptoms/conditions: NA, who was treated with Betamethasone Sodium Phosphate (dosage: Unk Unk, Qid, start time: 201108), combined with:
  • Diclofenac Sodium (Unk Unk, Qid)
  • Celecox
and developed a serious reaction and side effect(s). The consumer presented with:
  • Corneal Perforation
  • Ulcerative Keratitis
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Betamethasone Sodium Phosphate treatment in male patients, resulting in corneal perforation side effect.

Hypersensitivity, Asthma, Cough
This report suggests a potential Betamethasone Valerate Hypersensitivity, Asthma, Cough side effect(s) that can have serious consequences. A 55-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: rash and used Betamethasone Valerate (dosage: NA) starting Feb 21, 2013. Soon after starting Betamethasone Valerate the patient began experiencing various side effects, including:
  • Hypersensitivity
  • Asthma
  • Cough
Drugs used concurrently: NA. Although Betamethasone Valerate demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as hypersensitivity, may still occur.

Meningitis
This Meningitis problem was reported by a health professional from US. A 60-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: pain management. On Sep 25, 2012 this consumer started treatment with Betamethasone (dosage: 1 Ml 1 Epidural). The following drugs were being taken at the same time: NA. When commencing Betamethasone, the patient experienced the following unwanted symptoms/side effects:
  • Meningitis
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as meningitis, may become evident only after a product is in use by the general population.

Fatigue, Depression
This is a report of a 60-year-old male patient (weight: NA) from JP. The patient developed the following symptoms/conditions: fatigue and was treated with Betamethasone (dosage: 2 Mg, Qd) starting NS. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Fatigue
  • Depression
The patient was hospitalized. This opens a possibility that Betamethasone treatment could cause the above reactions, including fatigue, and some male subjects may be more susceptible.

Dermatitis Contact
A 55-year-old male patient (weight: NA) from US with the following symptoms/conditions: NA started Betamethasone Valerate treatment (dosage: NA) on Oct 01, 2012. Soon after starting Betamethasone Valerate treatment, the subject experienced various side effects, including:
  • Dermatitis Contact
Concurrently used drugs: NA. This finding indicates that some male patients could be more vulnerable to Betamethasone Valerate.

  2 of 22 



Top 10 Betamethasone Side Effects for Men

Men Side EffectsReports
Dyspnoea 10
Fall 10
Hypertension 10
Pyrexia 10
Erythema 9
Condition Aggravated 8
Insomnia 8
Haemorrhagic Stroke 7
Malaise 7
Pneumonia 7

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Betamethasone Side Effects

    Did You Have a Betamethasone Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Betamethasone for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Betamethasone Safety Alerts, Active Ingredients, Usage Information

    NDC0115-1472
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameBetamethasone
    NameBetamethasone
    Dosage FormCREAM
    RouteTOPICAL
    On market since20040123
    LabelerGlobal Pharmaceuticals, Division of Impax Laboratories Inc.
    Active Ingredient(s)BETAMETHASONE DIPROPIONATE
    Strength(s)0.5
    Unit(s)mg/g
    Pharma ClassCorticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]

    More About Betamethasone

    Side Effects reported to FDA: 527

    Betamethasone safety alerts: No

    Reported deaths: 39

    Reported hospitalizations: 153

    Latest Betamethasone clinical trials